Global DTaP and Tdap Vaccines Market Professional Survey Report 2019

Choose License

Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF?s total procurement.

Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.

The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%?85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.

The global DTaP and Tdap Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on DTaP and Tdap Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall DTaP and Tdap Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of DTaP and Tdap Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their DTaP and Tdap Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. 

The following manufacturers are covered:
    Sanofi Pasteur
    GlaxoSmithKline
    Protein Sciences Corporation
    Novartis AG
    Seqirus
    Merck Sharp & Dohme Corp
    Astellas Pharma US, Inc
    Pfizer Inc
    Johnson & Johnson
    Lanzhou Institute of Biological Products Co., Ltd
    AstraZeneca
    Emergent BioSolutions Inc

Segment by Regions
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

Segment by Type
    DTaP
    Td
    Tdap

Segment by Application
    Adult
    Pediatric
Table of Contents

Executive Summary
1 Industry Overview of DTaP and Tdap Vaccines
    1.1 Definition of DTaP and Tdap Vaccines
    1.2 DTaP and Tdap Vaccines Segment by Type
        1.2.1 Global DTaP and Tdap Vaccines Production Growth Rate Comparison by Types (2014-2025)
        1.2.2 DTaP
        1.2.3 Td
        1.2.4 Tdap
    1.3 DTaP and Tdap Vaccines Segment by Applications
        1.3.1 Global DTaP and Tdap Vaccines Consumption Comparison by Applications (2014-2025)
        1.3.2 Adult
        1.3.3 Pediatric
    1.4 Global DTaP and Tdap Vaccines Overall Market
        1.4.1 Global DTaP and Tdap Vaccines Revenue (2014-2025)
        1.4.2 Global DTaP and Tdap Vaccines Production (2014-2025)
        1.4.3 North America DTaP and Tdap Vaccines Status and Prospect (2014-2025)
        1.4.4 Europe DTaP and Tdap Vaccines Status and Prospect (2014-2025)
        1.4.5 China DTaP and Tdap Vaccines Status and Prospect (2014-2025)
        1.4.6 Japan DTaP and Tdap Vaccines Status and Prospect (2014-2025)
        1.4.7 Southeast Asia DTaP and Tdap Vaccines Status and Prospect (2014-2025)
        1.4.8 India DTaP and Tdap Vaccines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of DTaP and Tdap Vaccines
    2.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines
    2.4 Industry Chain Structure of DTaP and Tdap Vaccines

3 Development and Manufacturing Plants Analysis of DTaP and Tdap Vaccines
    3.1 Capacity and Commercial Production Date
    3.2 Global DTaP and Tdap Vaccines Manufacturing Plants Distribution
    3.3 Major Manufacturers Technology Source and Market Position of DTaP and Tdap Vaccines
    3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
    4.1 DTaP and Tdap Vaccines Production and Capacity Analysis
    4.2 DTaP and Tdap Vaccines Revenue Analysis
    4.3 DTaP and Tdap Vaccines Price Analysis
    4.4 Market Concentration Degree

5 DTaP and Tdap Vaccines Regional Market Analysis
    5.1 DTaP and Tdap Vaccines Production by Regions
        5.1.1 Global DTaP and Tdap Vaccines Production by Regions
        5.1.2 Global DTaP and Tdap Vaccines Revenue by Regions
    5.2 DTaP and Tdap Vaccines Consumption by Regions
    5.3 North America DTaP and Tdap Vaccines Market Analysis
        5.3.1 North America DTaP and Tdap Vaccines Production
        5.3.2 North America DTaP and Tdap Vaccines Revenue
        5.3.3 Key Manufacturers in North America
        5.3.4 North America DTaP and Tdap Vaccines Import and Export
    5.4 Europe DTaP and Tdap Vaccines Market Analysis
        5.4.1 Europe DTaP and Tdap Vaccines Production
        5.4.2 Europe DTaP and Tdap Vaccines Revenue
        5.4.3 Key Manufacturers in Europe
        5.4.4 Europe DTaP and Tdap Vaccines Import and Export
    5.5 China DTaP and Tdap Vaccines Market Analysis
        5.5.1 China DTaP and Tdap Vaccines Production
        5.5.2 China DTaP and Tdap Vaccines Revenue
        5.5.3 Key Manufacturers in China
        5.5.4 China DTaP and Tdap Vaccines Import and Export
    5.6 Japan DTaP and Tdap Vaccines Market Analysis
        5.6.1 Japan DTaP and Tdap Vaccines Production
        5.6.2 Japan DTaP and Tdap Vaccines Revenue
        5.6.3 Key Manufacturers in Japan
        5.6.4 Japan DTaP and Tdap Vaccines Import and Export
    5.7 Southeast Asia DTaP and Tdap Vaccines Market Analysis
        5.7.1 Southeast Asia DTaP and Tdap Vaccines Production
        5.7.2 Southeast Asia DTaP and Tdap Vaccines Revenue
        5.7.3 Key Manufacturers in Southeast Asia
        5.7.4 Southeast Asia DTaP and Tdap Vaccines Import and Export
    5.8 India DTaP and Tdap Vaccines Market Analysis
        5.8.1 India DTaP and Tdap Vaccines Production
        5.8.2 India DTaP and Tdap Vaccines Revenue
        5.8.3 Key Manufacturers in India
        5.8.4 India DTaP and Tdap Vaccines Import and Export

6 DTaP and Tdap Vaccines Segment Market Analysis (by Type)
    6.1 Global DTaP and Tdap Vaccines Production by Type
    6.2 Global DTaP and Tdap Vaccines Revenue by Type
    6.3 DTaP and Tdap Vaccines Price by Type

7 DTaP and Tdap Vaccines Segment Market Analysis (by Application)
    7.1 Global DTaP and Tdap Vaccines Consumption by Application
    7.2 Global DTaP and Tdap Vaccines Consumption Market Share by Application (2014-2019)

8 DTaP and Tdap Vaccines Major Manufacturers Analysis
    8.1 Sanofi Pasteur
        8.1.1 Sanofi Pasteur DTaP and Tdap Vaccines Production Sites and Area Served
        8.1.2 Sanofi Pasteur Product Introduction, Application and Specification
        8.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.1.4 Main Business and Markets Served
    8.2 GlaxoSmithKline
        8.2.1 GlaxoSmithKline DTaP and Tdap Vaccines Production Sites and Area Served
        8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
        8.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.2.4 Main Business and Markets Served
    8.3 Protein Sciences Corporation
        8.3.1 Protein Sciences Corporation DTaP and Tdap Vaccines Production Sites and Area Served
        8.3.2 Protein Sciences Corporation Product Introduction, Application and Specification
        8.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.3.4 Main Business and Markets Served
    8.4 Novartis AG
        8.4.1 Novartis AG DTaP and Tdap Vaccines Production Sites and Area Served
        8.4.2 Novartis AG Product Introduction, Application and Specification
        8.4.3 Novartis AG DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.4.4 Main Business and Markets Served
    8.5 Seqirus
        8.5.1 Seqirus DTaP and Tdap Vaccines Production Sites and Area Served
        8.5.2 Seqirus Product Introduction, Application and Specification
        8.5.3 Seqirus DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.5.4 Main Business and Markets Served
    8.6 Merck Sharp & Dohme Corp
        8.6.1 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Sites and Area Served
        8.6.2 Merck Sharp & Dohme Corp Product Introduction, Application and Specification
        8.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.6.4 Main Business and Markets Served
    8.7 Astellas Pharma US, Inc
        8.7.1 Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Sites and Area Served
        8.7.2 Astellas Pharma US, Inc Product Introduction, Application and Specification
        8.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.7.4 Main Business and Markets Served
    8.8 Pfizer Inc
        8.8.1 Pfizer Inc DTaP and Tdap Vaccines Production Sites and Area Served
        8.8.2 Pfizer Inc Product Introduction, Application and Specification
        8.8.3 Pfizer Inc DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.8.4 Main Business and Markets Served
    8.9 Johnson & Johnson
        8.9.1 Johnson & Johnson DTaP and Tdap Vaccines Production Sites and Area Served
        8.9.2 Johnson & Johnson Product Introduction, Application and Specification
        8.9.3 Johnson & Johnson DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.9.4 Main Business and Markets Served
    8.10 Lanzhou Institute of Biological Products Co., Ltd
        8.10.1 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Sites and Area Served
        8.10.2 Lanzhou Institute of Biological Products Co., Ltd Product Introduction, Application and Specification
        8.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        8.10.4 Main Business and Markets Served
    8.11 AstraZeneca
    8.12 Emergent BioSolutions Inc

9 Development Trend of Analysis of DTaP and Tdap Vaccines Market
    9.1 Global DTaP and Tdap Vaccines Market Trend Analysis
        9.1.1 Global DTaP and Tdap Vaccines Market Size (Volume and Value) Forecast 2019-2025
    9.2 DTaP and Tdap Vaccines Regional Market Trend
        9.2.1 North America DTaP and Tdap Vaccines Forecast 2019-2025
        9.2.2 Europe DTaP and Tdap Vaccines Forecast 2019-2025
        9.2.3 China DTaP and Tdap Vaccines Forecast 2019-2025
        9.2.4 Japan DTaP and Tdap Vaccines Forecast 2019-2025
        9.2.5 Southeast Asia DTaP and Tdap Vaccines Forecast 2019-2025
        9.2.6 India DTaP and Tdap Vaccines Forecast 2019-2025
    9.3 DTaP and Tdap Vaccines Market Trend (Product Type)
    9.4 DTaP and Tdap Vaccines Market Trend (Application)

10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.3 DTaP and Tdap Vaccines Customers

11 Market Dynamics
    11.1 Market Trends
    11.2 Opportunities
    11.3 Market Drivers
    11.4 Challenges
    11.5 Influence Factors

12 Conclusion
13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Author List
    13.4 Disclaimer

List of Tables and Figures Figure Picture of DTaP and Tdap Vaccines Table Global DTaP and Tdap Vaccines Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global DTaP and Tdap Vaccines Production Market Share by Types in 2018 Figure DTaP Product Picture Figure Td Product Picture Figure Tdap Product Picture Table Global DTaP and Tdap Vaccines Consumption (K Units) Comparison by Applications (2014-2025) Figure Global DTaP and Tdap Vaccines Consumption Market Share by Applications in 2018 Figure Adult Figure Pediatric Figure Global DTaP and Tdap Vaccines Revenue (Million USD) (2014-2025) Figure Global DTaP and Tdap Vaccines Production (K Units) (2014-2025) Figure North America DTaP and Tdap Vaccines Market Size (Million USD) (2014-2025) Figure Europe DTaP and Tdap Vaccines Market Size (Million USD) (2014-2025) Figure China DTaP and Tdap Vaccines Market Size (Million USD) (2014-2025) Figure Japan DTaP and Tdap Vaccines Market Size (Million USD) (2014-2025) Figure Southeast Asia DTaP and Tdap Vaccines Market Size (Million USD) (2014-2025) Figure India DTaP and Tdap Vaccines Market Size (Million USD) (2014-2025) Table DTaP and Tdap Vaccines Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of DTaP and Tdap Vaccines in 2018 Figure Manufacturing Process Analysis of DTaP and Tdap Vaccines Figure Industry Chain Structure of DTaP and Tdap Vaccines Table Capacity and Commercial Production Date of Key Manufacturers Table Global DTaP and Tdap Vaccines Manufacturing Plants Distribution Table DTaP and Tdap Vaccines Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table DTaP and Tdap Vaccines Capacity (K Units) of Major Manufacturers (2014-2019) Table DTaP and Tdap Vaccines Production (K Units) of Major Manufacturers (2014-2019) Table DTaP and Tdap Vaccines Production Market Share of Major Manufacturers (2014-2019) Figure DTaP and Tdap Vaccines Production Share by Manufacturers in 2018 Table DTaP and Tdap Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019) Table DTaP and Tdap Vaccines Revenue Market Share of Major Manufacturers (2014-2019) Figure DTaP and Tdap Vaccines Revenue Share by Manufacturers in 2018 Table DTaP and Tdap Vaccines Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global DTaP and Tdap Vaccines Production by Regions 2014-2019 (K Units) Table Global DTaP and Tdap Vaccines Production Market Share by Regions 2014-2019 Figure Global DTaP and Tdap Vaccines Production Market Share by Regions in 2018 Table Global DTaP and Tdap Vaccines Revenue by Regions 2014-2019 (Million USD) Table Global DTaP and Tdap Vaccines Revenue Market Share by Regions 2014-2019 Figure Global DTaP and Tdap Vaccines Revenue Market Share by Regions in 2018 Table Global DTaP and Tdap Vaccines Consumption by Regions 2014-2019 (K Units) Table Global DTaP and Tdap Vaccines Consumption Market Share by Regions 2014-2019 Figure North America DTaP and Tdap Vaccines Production Growth Rate 2014-2019 (K Units) Figure North America DTaP and Tdap Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table North America DTaP and Tdap Vaccines Production, Consumption Import and Export (K Units) Figure Europe DTaP and Tdap Vaccines Production Growth Rate 2014-2019 (K Units) Figure Europe DTaP and Tdap Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Europe DTaP and Tdap Vaccines Production, Consumption Import and Export (K Units) Figure China DTaP and Tdap Vaccines Production Growth Rate 2014-2019 (K Units) Figure China DTaP and Tdap Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table China DTaP and Tdap Vaccines Production, Consumption Import and Export (K Units) Figure Japan DTaP and Tdap Vaccines Production Growth Rate 2014-2019 (K Units) Figure Japan DTaP and Tdap Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Japan DTaP and Tdap Vaccines Production, Consumption Import and Export (K Units) Figure Southeast Asia DTaP and Tdap Vaccines Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia DTaP and Tdap Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia DTaP and Tdap Vaccines Production, Consumption Import and Export (K Units) Figure India DTaP and Tdap Vaccines Production Growth Rate 2014-2019 (K Units) Figure India DTaP and Tdap Vaccines Revenue Growth Rate 2014-2019 (Million USD) Table India DTaP and Tdap Vaccines Production, Consumption Import and Export (K Units) Figure Global Consumption DTaP and Tdap Vaccines Market Share by Application (2014-2019) Figure Global Value (Consumption) DTaP and Tdap Vaccines Market Share by Application (2014-2019) Table Sanofi Pasteur DTaP and Tdap Vaccines Production Sites and Area Served Table Sanofi Pasteur DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Sanofi Pasteur DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Pasteur DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Sanofi Pasteur DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Sanofi Pasteur DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Sanofi Pasteur DTaP and Tdap Vaccines Main Business and Markets Served Table GlaxoSmithKline DTaP and Tdap Vaccines Production Sites and Area Served Table GlaxoSmithKline DTaP and Tdap Vaccines Product Introduction, Application and Specification Table GlaxoSmithKline DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table GlaxoSmithKline DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure GlaxoSmithKline DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table GlaxoSmithKline DTaP and Tdap Vaccines Main Business and Markets Served Table Protein Sciences Corporation DTaP and Tdap Vaccines Production Sites and Area Served Table Protein Sciences Corporation DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Protein Sciences Corporation DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Protein Sciences Corporation DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Protein Sciences Corporation DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Protein Sciences Corporation DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Protein Sciences Corporation DTaP and Tdap Vaccines Main Business and Markets Served Table Novartis AG DTaP and Tdap Vaccines Production Sites and Area Served Table Novartis AG DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Novartis AG DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis AG DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Novartis AG DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Novartis AG DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Novartis AG DTaP and Tdap Vaccines Main Business and Markets Served Table Seqirus DTaP and Tdap Vaccines Production Sites and Area Served Table Seqirus DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Seqirus DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Seqirus DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Seqirus DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Seqirus DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Seqirus DTaP and Tdap Vaccines Main Business and Markets Served Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Sites and Area Served Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Main Business and Markets Served Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Sites and Area Served Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Astellas Pharma US, Inc DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Main Business and Markets Served Table Pfizer Inc DTaP and Tdap Vaccines Production Sites and Area Served Table Pfizer Inc DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Pfizer Inc DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Inc DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Pfizer Inc DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Pfizer Inc DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Pfizer Inc DTaP and Tdap Vaccines Main Business and Markets Served Table Johnson & Johnson DTaP and Tdap Vaccines Production Sites and Area Served Table Johnson & Johnson DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Johnson & Johnson DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Johnson & Johnson DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Johnson & Johnson DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Johnson & Johnson DTaP and Tdap Vaccines Main Business and Markets Served Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Sites and Area Served Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Introduction, Application and Specification Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Growth Rate (2014-2019) Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Market Share (2014-2019) Figure Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Revenue Market Share (2014-2019) Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Main Business and Markets Served Table AstraZeneca DTaP and Tdap Vaccines Production Sites and Area Served Table Emergent BioSolutions Inc DTaP and Tdap Vaccines Production Sites and Area Served Figure Global DTaP and Tdap Vaccines Production (K Units) Growth Rate Forecast 2019-2025 Figure Global DTaP and Tdap Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global DTaP and Tdap Vaccines Sales Price (USD/Unit) Forecast 2019-2025 Figure North America DTaP and Tdap Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure North America DTaP and Tdap Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe DTaP and Tdap Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe DTaP and Tdap Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China DTaP and Tdap Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure China DTaP and Tdap Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan DTaP and Tdap Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan DTaP and Tdap Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia DTaP and Tdap Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia DTaP and Tdap Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India DTaP and Tdap Vaccines Production Growth Rate Forecast 2019-2025 (K Units) Figure India DTaP and Tdap Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of DTaP and Tdap Vaccines by Type (2019-2025) Table Global Consumption (K Units) of DTaP and Tdap Vaccines by Application (2019-2025) Table DTaP and Tdap Vaccines Distributors List Table DTaP and Tdap Vaccines Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Food Grade Iron Powder Market Professional Survey Report 2019

Food Grade Iron Powder is suitable for use as a fortificant (food additive containing any bioavailable iron nutrient or for pigmentation) for different application/purpose. During the process of selection of iron compound as a food fortificant, the o...

Global Confectionery Ingredient Market Professional Survey Report 2019

Changing consumer lifestyles; R&D & product innovations, increasing demand for natural ingredients due to increasing consumer awareness, and health benefits of chocolates result in the growth of the demand of confectionery ingredients. The global ...

Global Civilian Less Lethal and Self Defense Weapons Market Professional Survey Report 2019

Civilians are showing a consistent increase in concern over personal safety, especially for the feminine population. This is the prime driver for civilian less lethal and self-defense weapons market. The global Civilian Less Lethal and Self Defens...

Global Chilled Rooms Market Professional Survey Report 2019

Chilled room is a refrigerated area for cold storage of perishable items, especially food, to preserve them. In a chilled room the temperature is typically between 0 - 5?C. The global Chilled Rooms market was valued at xx million US$ in 2018 and w...

Global Boron Compounds Market Professional Survey Report 2019

Boron compounds include all chemical compounds including the element boron. The global Boron Compounds market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This r...

New Pharmaceuticals and Healthcare Reports